Sands Capital Life Sciences Pulse Fund II, L.P. (CIK 0001875620)

Latest company ownership

Shares held
13,018,965
Last filed at
Nov 24, 2025
Confidence Score
87.5
2025Q4
Confidence Score History
2025Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 21, 2025 Nov 24, 2025 Inhibikase Therapeutics, Inc. 10% Owner Buy 100.0 +2,068,965 18.89% ✗ $3M